Stjernschantz J - Search Results

1

Ocular and systemic pharmacokinetics of latanoprost in humans.

Sjöquist B, Stjernschantz J. Sjöquist B, et al. Among authors: stjernschantz j. Surv Ophthalmol. 2002 Aug;47 Suppl 1:S6-12. doi: 10.1016/s0039-6257(02)00302-8. Surv Ophthalmol. 2002. PMID: 12204697

2

Studies on ocular inflammation and development of a prostaglandin analogue for glaucoma treatment.

Stjernschantz J. Stjernschantz J. Exp Eye Res. 2004 Apr;78(4):759-66. doi: 10.1016/j.exer.2003.11.016. Exp Eye Res. 2004. PMID: 15037110 Review.

3

Effects of intratympanic injection of latanoprost in Meniere's disease: a randomized, placebo-controlled, double-blind, pilot study.

Rask-Andersen H, Friberg U, Johansson M, Stjernschantz J. Rask-Andersen H, et al. Among authors: stjernschantz j. Otolaryngol Head Neck Surg. 2005 Sep;133(3):441-3. doi: 10.1016/j.otohns.2005.05.043. Otolaryngol Head Neck Surg. 2005. PMID: 16143197 Clinical Trial.

4

Production of prostaglandin e(2) by iridial melanocytes exposed to latanoprost acid, a prostaglandin F(2 alpha) analogue.

Bergh K, Wentzel P, Stjernschantz J. Bergh K, et al. Among authors: stjernschantz j. J Ocul Pharmacol Ther. 2002 Oct;18(5):391-400. doi: 10.1089/10807680260362678. J Ocul Pharmacol Ther. 2002. PMID: 12419090

5

Transcription of prostanoid receptor genes and cyclooxygenase enzyme genes in cultivated human iridial melanocytes from eyes of different colours.

Wentzel P, Bergh K, Wallin O, Niemelä P, Stjernschantz J. Wentzel P, et al. Among authors: stjernschantz j. Pigment Cell Res. 2003 Feb;16(1):43-9. doi: 10.1034/j.1600-0749.2003.00001.x. Pigment Cell Res. 2003. PMID: 12519124

6

Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgery.

Camras CB, Toris CB, Sjoquist B, Milleson M, Thorngren JO, Hejkal TW, Patel N, Barnett EM, Smolyak R, Hasan SF, Hellman C, Meza JL, Wax MB, Stjernschantz J. Camras CB, et al. Among authors: stjernschantz j. Ophthalmology. 2004 Dec;111(12):2193-8. doi: 10.1016/j.ophtha.2004.06.028. Ophthalmology. 2004. PMID: 15582073 Clinical Trial.

7

Mechanism and clinical significance of prostaglandin-induced iris pigmentation.

Stjernschantz JW, Albert DM, Hu DN, Drago F, Wistrand PJ. Stjernschantz JW, et al. Surv Ophthalmol. 2002 Aug;47 Suppl 1:S162-75. doi: 10.1016/s0039-6257(02)00292-8. Surv Ophthalmol. 2002. PMID: 12204714 Review.

8

From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture.

Stjernschantz JW. Stjernschantz JW. Invest Ophthalmol Vis Sci. 2001 May;42(6):1134-45. Invest Ophthalmol Vis Sci. 2001. PMID: 11328719 Review. No abstract available.

9

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

Watson P, Stjernschantz J. Watson P, et al. Among authors: stjernschantz j. Ophthalmology. 1996 Jan;103(1):126-37. doi: 10.1016/s0161-6420(96)30750-1. Ophthalmology. 1996. PMID: 8628543 Clinical Trial.

10

Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimens.

Nagasubramanian S, Sheth GP, Hitchings RA, Stjernschantz J. Nagasubramanian S, et al. Among authors: stjernschantz j. Ophthalmology. 1993 Sep;100(9):1305-11. doi: 10.1016/s0161-6420(13)31817-x. Ophthalmology. 1993. PMID: 8371916 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results